Social phobia: long‐term treatment outcome and prediction of response - a moclobemide study

  title={Social phobia: long‐term treatment outcome and prediction of response - a moclobemide study},
  author={M{\'a}rcio Versiani and R. Amrein and Stuart A. Montgomery},
  journal={International Clinical Psychopharmacology},
In this open, prospective, structured, naturalistic study of the efficacy of long-term treatment in social phobia 93 consecutive outpatients suffering from severe generalized or circumscribed social phobia (median Liebowitz. Social Anxiety Scale score 83) and a high degree of concomitant psychiatric disease were administered treatment with moclobemide (712 ± 75 mg/day at steady state). Fifty-nine patients who responded (Clinical Global Impression for Change: very much/much improved) completed 2… Expand
Predictors of Response in Generalized Social Phobia: Effect of Age of Onset
Abstract: Selective serotonin reuptake inhibitors (SSRIs) are the gold standard for the pharmacological treatment of generalized social phobia (GSP). However, little is known about the predictors ofExpand
Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study
It is suggested that a ≥10% reduction in the LSAS total score in a week can predict endpoint treatment response, and the early improvement group at 1 week of treatment was expected to show stronger endpoint responses compared to the group with no early improvement. Expand
Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings
The results of the present study suggest that citalopram has shown promising results in patients with social phobia and moclobemide, the only MAOI used in Turkey, is suggested to be an SSRI. Expand
Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder
In a large sample of social anxiety disorder patients with and without comorbid anxiety disorders, moclobemide was both effective and well-tolerated in the short as well as long-term, and strengthen the range of therapeutic options for managing this important disorder. Expand
Effectiveness of Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia
Background: A few studies on short-term psychodynamic approach have been conducted on social phobia. Objectives: In this study, the effectiveness of short-term psychodynamic psychotherapy on theExpand
Comparison of Treatment Adherence between Selective Serotonin Reuptake Inhibitors and Moclobemide in Patients with Social Anxiety Disorder
The SSRI group had a longer treatment duration and lower all-cause discontinuation rate than moclobemide and therefore, could predict better treatment adherence with the SSRIs in the treatment of SAD. Expand
Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia
The results indicated that short-term dynamic psychotherapy sertraline are effective in decreasing social phobia symptoms and were superior to control group. Expand
Optimizing Treatment in Social Phobia: A Review of Treatment Resistance
A review of the current literature and issues related to treatment-resistant SP, including a discussion of the functional impairment associated with SP, definitions of treatment response and remission, as well as outcome measures that have been used in clinical investigations of SP are presented. Expand
Social phobia: diagnosis, severity and implications for treatment
  • S. Montgomery
  • Psychology, Medicine
  • European Archives of Psychiatry and Clinical Neuroscience
  • 1999
Effective treatment of social phobia appears to be able to overcome the substantial chronicity of illness which is frequent in sufferers. Expand
A review on predictors of treatment outcome in social anxiety disorder.
Early onset, greater disease severity, comorbidity with other anxiety disorders, and high expectations about the role of the therapist emerged as potential predictors of less effective treatment in patients with social anxiety disorder. Expand